{
    "eid": "2-s2.0-85020232804",
    "title": "Lime powder treatment reduces urinary excretion of total protein and transferrin but increases uromodulin excretion in patients with urolithiasis",
    "cover-date": "2018-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Urology",
            "@code": "2748",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Calcium oxalate",
        "Kidney stone",
        "Proteome",
        "Proteomics",
        "THP",
        "Urinary proteins"
    ],
    "authors": [
        "Piyaratana Tosukhowong",
        "Pimsuda Kulpradit",
        "Sakdithep Chaiyarit",
        "Wattanachai Ungjareonwattana",
        "Nuttiya Kalpongnukul",
        "Supoj Ratchanon",
        "Visith Thongboonkerd"
    ],
    "citedby-count": 13,
    "ref-count": 33,
    "ref-list": [
        "Lithiasis and risk factors",
        "Incidence of urolithiasis in northeast Thailand",
        "The first kidney stone",
        "Renal tubular damage/dysfunction: key to the formation of kidney stones",
        "Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment",
        "Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis",
        "Kidney stones and the risk for chronic kidney disease",
        "ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention",
        "Renal function in patients with nephrolithiasis",
        "Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III",
        "Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients",
        "Inflammatory and fibrotic proteins proteomically identified as key protein constituents in urine and stone matrix of patients with kidney calculi",
        "Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation",
        "Proteins and other biocolloids of urine in health and in calculous disease. I. Electrophoretic studies at pH 4.5 and 8.6 of those components soluble in molar sodium chloride",
        "In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers",
        "Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor",
        "Proteomic analysis of calcium oxalate monohydrate crystal-induced cytotoxicity in distal renal tubular cells",
        "Differential colony size, cell length, and cellular proteome of Escherichia coli isolated from urine vs. stone nidus of kidney stone patients",
        "Prospects for proteomics in kidney stone disease",
        "Kidney stones: pathophysiology and medical management",
        "Management of kidney stone disease in New South Wales",
        "Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation",
        "Second prize: comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix",
        "Assessment of urine proteomics in Type 1 primary hyperoxaluria",
        "Urinary biomarkers in the assessment of early diabetic nephropathy",
        "Tamm-Horsfall glycoprotein: biology and clinical relevance",
        "Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation",
        "Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation",
        "Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine?",
        "Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers",
        "Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients",
        "Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions",
        "Anti-inflammatory effects of calcium citrate in RAW 264.7cells via suppression of NF-kappaB activation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60011189",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ubon Ratchathani",
            "@id": "114402284",
            "affilname": "Sappasit Prasong Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114402284",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Research Council of Thailand, Mahidol University",
        "National Research Universities Initiative",
        "Office of the Higher Education Commission",
        "Mahidol University",
        "Thailand Research Fund",
        "Faculty of Medicine Siriraj Hospital"
    ]
}